Key terms
About ACOR
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine), and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ACOR news
No recent news articles are available for ACOR
No recent press releases are available for ACOR
ACOR Financials
Key terms
Ad Feedback
ACOR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ACOR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range